See also this year's filing and all EDGAR filings for this company.
PDF Report 0001481512_2017_Ra_Pharmaceuticals_Inc.pdf
Logs
warning | Missing logo | subcommand.report | {} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001481512')"} |
Graph
Absolute values for 0001481512, Ra Pharmaceuticals Inc.
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 119,502,000 |
1 | IntangibleAssetsNetIncludingGoodwill | 445,000 |
2 | PropertyPlantAndEquipmentNet | 5,537,000 |
3 | remainder_Assets | 1,334,000 |
4 | LiabilitiesCurrent | 6,737,000 |
5 | LiabilitiesNoncurrent | 0 |
6 | remainder_Liabilities | 2,859,000 |
7 | CostOfGoodsAndServicesSold | 0 |
8 | SellingGeneralAndAdministrativeExpense | 5,024,000 |
9 | ResearchAndDevelopmentExpense | 27,928,000 |
10 | remainder_Expenses | -18,000 |
11 | remainder_Revenues | 4,928,000 |
12 | remainder_NetIncome | -858,000 |
13 | remainder_ComprehensiveNetIncome | 0 |
yvar | yval | |
---|---|---|
0 | Assets | 126,818,000 |
1 | Liabilities | 9,596,000 |
2 | Expenses | 32,934,000 |
3 | Revenues | 4,928,000 |
4 | StockholdersEquity | 117,222,000 |
5 | NetIncome | -28,864,000 |
6 | ComprehensiveNetIncome | -28,864,000 |
7 | BaseVar | 87,567,000 |
8 | EconomicCapitalRatio | 2.53 |